Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0696 per EA under NDC 13107008501. Its NADAC has been published 403 times since Oct 10, 2018.
Strength
2 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107008501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203572On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 403 times since Oct 10, 2018, and over the history we have for it it has risen 42.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0696 per EA |
|---|---|
| All-time high | $0.0866 (Jan 10, 2024) |
| All-time low | $0.0488 (Oct 10, 2018) |
| 52-week high | $0.0764 |
| 52-week low | $0.0695 |
| Median price | $0.0695 |
| Average price | $0.0688 |
| Largest weekly change | -30.9% (Nov 20, 2024) |
| Weeks tracked | 403 |
| Tracking since | Oct 10, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0696 per EA (NDC 13107008501), effective Jun 24, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has risen 42.7%. It has been tracked across 403 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since Oct 10, 2018, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0488 (Oct 10, 2018) to a high of $0.0866 (Jan 10, 2024), with a median of $0.0695 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LORAZEPAM 2 MG TABLET, but none are currently priced below it.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 13107008501) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification